Treatment pathways and associated costs of metastatic colorectal cancer in Greece.

ABSTRACT:

Objectives

Colorectal cancer (CRC) is the second leading cause of cancer in Europe, with 1.931.590 people newly diagnosed in 2020. The purpose of this study is the investigation of treatment options and healthcare resource metastatic CRC (mCRC) in Greece.

Methods

This study is based on the information collected in November 2020 by an expert panel comprising of 6 medical oncologists from major public and private centers around Greece. A 3-round survey was undertaken, according to Delphi method. The treatment phases studied were: pre-progression; disease progression and terminal care. Pharmaceutical costs and resource utilization data were considered from the perspective of the Greek National Services Organization (EOPYY).

Results

Experts agreed that the anticipated pre

SUBMITTER: Sougklakos I 

PROVIDER: S-EPMC8842737 | biostudies-literature | 2022 Feb

REPOSITORIES: biostudies-literature